Skip to content

Application of dexmedetomidine combined with femoral nerve block in total knee arthroplasty and their effects on postoperative recovery

Application of dexmedetomidine combined with femoral nerve block in total knee arthroplasty and their effects on postoperative recovery

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900027552
Enrollment
Unknown
Registered
2019-11-17
Start date
2019-12-24
Completion date
Unknown
Last updated
2021-02-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

total knee arthroplasty

Interventions

DF group:Intravenous pumping of dexmedetomidine
SF group:sciatic nerve block

Sponsors

The First Affiliated Hospital of Anhui Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Aged 50-80 years; 2. ASA level 2-3; 3. Subjects or family members sign informed consent voluntarily; 4. Normal ability of communication and learning.

Exclusion criteria

Exclusion criteria: 1. Knee replacement due to trauma; 2. Be allergic to dexmedetomidine and the drugs needed in the study; 3. There are contraindications to nerve block; 4. Severe bradycardia 100 min) or insufficient (<30 min) tourniquet duration; 9. serious postoperative complication.

Design outcomes

Primary

MeasureTime frame
the duration of analgesia;

Secondary

MeasureTime frame
the total dosage of sufentanil;postoperative pain score;the proportion of patients without postoperative rescue analgesia;the occurrence rate of postoperative delirium;the occurrence rate of postoperative nausea and vomiing;the occurrence rate of tourniquet-induced reponse;the first time to walk with a walker;the length of hospital stay;the dose of postoperative rescue analgesia;the dose of intraoperative vasoactive drugs;extubation time and the duration in PACU;the maintenance dose of propofol;

Countries

China

Contacts

Public ContactXu Guanghong

The First Affiliated Hospital of Anhui Medical University

xuguanghong2004@163.com+86 13856949535

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 13, 2026